Skip to main content Accessibility help
  • Print publication year: 2017
  • Online publication date: September 2017

7 - Effect of Reminders of Personal Sacrifice and Suggested Rationalizations on Residents’ Self-Reported Willingness to Accept Gifts: A Randomized Trial

from Part III - Psychological Insights into Bribery
Adams, J. S. (1965). Inequity in social exchange. Advances in Experimental Social Psychology, 2, 267299.
Babcock, L., Loewenstein, G., Issacharoff, S., & Camerer, C. (1995). Biased judgments of fairness in bargaining. American Economic Review, 85, 13371343.
Brennan, T. A., Rothman, D. J., Blank, L., et al. (2006). Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA, 295(4), 429433.
Campbell, E. G. (2007). Doctors and drug companies – Scrutinizing influential relationships. New England Journal of Medicine, 357(18), 17961797.
Campbell, E. G., Gruen, R. L., Mountford, J., Miller, L. G., Cleary, P. D., & Blumenthal, D. (2007). A national survey of physician-industry relationships. New England Journal of Medicine, 356(17), 17421750.
Chimonas, S., Brennan, T. A., & Rothman, D. J. (2007). Physicians and drug representatives: Exploring the dynamics of the relationship. Journal of General Internal Medicine, 22(2), 184190.
Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (1983). Applied Multiple Regression/Correlation for the Behavioral Sciences. Hillsdale, NJ: Erlbaum.
Dana, J., & Loewenstein, G. (2003). A social science perspective on gifts to physicians from industry. JAMA, 290(2), 252255.
Fugh-Berman, A., & Ahari, S. (2007). Following the script: How drug reps make friends and influence doctors. PLoS Med, 4(4), e150.
King-Casas, B., Tomlin, D., Anen, C., Camerer, C. F., Quartz, S. R., & Montague, P. R. (2005). Getting to know you: Reputation and trust in a two-person economic exchange. Science, 308(5718), 7883.
Mazar, N., Amir, O., & Ariely, D. (2008). The dishonesty of honest people: A theory of self-concept maintenance. Journal of Marketing Research, 45(6), 633644.
Montague, R. (2007). The perspective from neuroscience. The Scientific Basis of Influence and Reciprocity: A Symposium. Last accessed August 19, 2010.
Sierles, F. S., Brodkey, A. C., Cleary, L. M., et al. (2005). Medical students’ exposure to and attitudes about drug company interactions: A national survey. JAMA, 294(9), 10341042.
Steinman, M. A., Bero, L. A., Chren, M. M., & Landefeld, C. S. (2006). Narrative review: The promotion of gabapentin: An analysis of internal industry documents. Annals of Internal Medicine, 145(4), 284293.
Steinman, M. A., Harper, G. M., Chren, M. M., Landefeld, C. S., & Bero, L. A. (2007). Characteristics and impact of drug detailing for gabapentin. PLoS Med, 4(4), e134.
Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA, 283(3), 373380.
Zipkin, D. A., & Steinman, M. A. (2005). Interactions between pharmaceutical representatives and doctors in training: A thematic review. Journal of General Internal Medicine, 20(8), 777786.